Table 1. Patients’ characteristics.
| Case | Age | Sex | NIHSS | Lesion site | Af | HT | HL | DM | Prior antithrombotic therapy | Hyperdense CT sign | WBC (/μg) | Neu (/μg) | CRP (mg/dL) | D-dimer (μg/mL) | Fibrinogen (mg/dL) | t-PA | Onset-to-puncture time (min) | Onset-to-recanalization time (min) | Pass number | TICI grade | mRS | TOAST classification |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 90 | F | 7 | Rt IC | – | + | + | + | – | – | 5320 | 3940 | 0.18 | 2.9 | N/A | + | 395 | 455 | 1 | 3 | 6 | LAO |
| 2 | 79 | M | 15 | Lt IC | + | + | + | + | Warfarin 2 mg | + | 4920 | 2910 | 0.10 | 0.4 | 407 | – | 130 | 520 | 1 | 3 | 2 | CE |
| 3 | 79 | F | 24 | Lt IC | + | + | – | – | Clopidogrel 75 mg | – | 5320 | 3850 | 0.39 | 3.9 | 522 | + | 275 | 310 | 2 | 3 | 5 | CE |
| 4 | 94 | F | 25 | BA | + | + | + | – | Aspirin 100 mg | – | 6600 | 5180 | 0.42 | 4.4 | 378 | – | 210 | 475 | 1 | 3 | 6 | CE |
| 5 | 78 | M | 14 | Rt IC | + | + | + | – | Clopidogrel 75 mg | – | 5530 | 3660 | 0.05 | 1.9 | 375 | + | 145 | 180 | 1 | 3 | 3 | CE |
| 6 | 76 | F | 16 | Lt M1 | – | + | + | – | Clopidogrel 75 mg | + | 4060 | 2900 | 0.82 | 0.4 | 374 | + | 180 | 270 | 3 | 2B | 4 | CE |
Af: atrial fibrillation; BA: basilar artery; CE: cardioembolism; CRP: C-reactive protein; DM: diabetes mellitus; HL: hyperlipidemia; HT: hypertension; IC: internal carotid artery; LAO: large-artery atherosclerosis; mRS: modified Rankin Scale; M1: middle cerebral artery M1 section; Neu: neutrophil count; NIHSS: National Institutes of Health Stroke Scale; t-PA: tissue plasminogen activator; TICI: thrombolysis in cerebral infarction score; TOAST: trial of ORG 10172 in acute stroke treatment; WBC: white blood cells